SCHEDULE 13G: William Blair Investment Management Discloses 6.4% Stake in Twist Bioscience Corp

William Blair Investment Management, LLC has disclosed a 6.4% beneficial ownership stake in Twist Bioscience Corp, holding 3,806,867 shares of common stock.

Summary

• William Blair Investment Management, LLC has filed a Schedule 13G, indicating beneficial ownership of common stock in Twist Bioscience Corp.
• The filing reports an aggregate beneficial ownership of 3,806,867 shares of Twist Bioscience Corp common stock.
• This ownership represents 6.4% of the outstanding common stock of Twist Bioscience Corp.
• William Blair Investment Management, LLC holds sole voting power over 3,538,080 shares and sole dispositive power over all 3,806,867 shares.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: The filing is largely neutral as it is a factual disclosure of ownership. However, the disclosure of a significant stake by a reputable investment firm can be viewed as a positive signal of institutional confidence, hence slightly above neutral.

Positives

• The disclosure of a significant institutional ownership stake by William Blair Investment Management, LLC, a reputable investment firm, could signal confidence in Twist Bioscience Corp's prospects.

Negatives

• The Schedule 13G filing itself does not contain any negative information regarding Twist Bioscience Corp's operations or financial performance.

Risks

• The Schedule 13G filing is a disclosure of ownership and does not detail specific risks related to Twist Bioscience Corp's business operations or financial health.

Future Outlook

The Schedule 13G filing is a disclosure of current ownership and does not contain any forward-looking statements or guidance regarding Twist Bioscience Corp's future performance or outlook.

Industry Context

This filing is a standard disclosure of a significant ownership stake by an institutional investment manager in a biotechnology company. It does not provide specific insights into broader industry trends beyond indicating continued institutional interest in the sector.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant institutional ownership, which may be viewed positively as a vote of confidence in the company.

Key Dates

Keywords

Twist Bioscience Corp, William Blair Investment Management, Schedule 13G, Common Stock, Beneficial Ownership, Institutional Investor, SEC Filing, Biotechnology, Synthetic Biology